GFM
CAI

GF Fund Management’s Caris Life Sciences CAI Stock Holding History

GF Fund Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Sell
5,970
-367
-6% -$6.57K ﹤0.01% 329
2026
Q1 		$113K Buy
6,337
+794
+14% +$17.4K ﹤0.01% 330
2025
Q4 		$150K Buy
+5,543
New +$156K ﹤0.01% 316

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GF Fund Management's CAI Position: Q2 2026 in Review

GF Fund Management reduced its Caris Life Sciences (CAI) stake by 5.8% in Q2 2026, selling an estimated $6.57K and leaving 5,970 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #329.

GF Fund Management first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. The position peaked at $150K in Q4 2025. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • GF Fund Management held 5,970 shares of Caris Life Sciences worth $106K as of Q2 2026.
  • GF Fund Management sold 367 Caris Life Sciences shares in Q2 2026, an estimated $6.57K.
  • Caris Life Sciences made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #329 holding.
  • GF Fund Management first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • GF Fund Management's Caris Life Sciences position peaked at $150K in Q4 2025.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.